Anti-Cancer Agent, Herceptin Obtained Approval for Dosage and Administration for Postoperative Adjuvant Chemotherapy in Breast Cancer in Japan

Please find attached a press release by Chugai
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news